De Lisle Partners LLP Has $1.98 Million Holdings in Nutrien Ltd. $NTR

De Lisle Partners LLP lessened its holdings in Nutrien Ltd. (NYSE:NTRFree Report) by 23.8% during the fourth quarter, HoldingsChannel reports. The fund owned 32,000 shares of the company’s stock after selling 10,000 shares during the quarter. De Lisle Partners LLP’s holdings in Nutrien were worth $1,975,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Montag A & Associates Inc. raised its holdings in shares of Nutrien by 310.7% in the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock worth $26,000 after acquiring an additional 320 shares during the last quarter. Sfam LLC acquired a new stake in shares of Nutrien in the 4th quarter worth about $37,000. Eastern Bank raised its holdings in shares of Nutrien by 133.0% in the 4th quarter. Eastern Bank now owns 699 shares of the company’s stock worth $43,000 after acquiring an additional 399 shares during the last quarter. Harbour Investments Inc. raised its holdings in shares of Nutrien by 97.2% in the 4th quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock worth $43,000 after acquiring an additional 347 shares during the last quarter. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Nutrien by 42.4% in the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after acquiring an additional 219 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Trading Up 3.2%

Shares of NTR stock opened at $67.65 on Friday. The company has a 50 day moving average of $71.34 and a 200-day moving average of $69.17. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35. Nutrien Ltd. has a 12-month low of $53.03 and a 12-month high of $85.36. The firm has a market cap of $32.47 billion, a P/E ratio of 13.78, a PEG ratio of 0.60 and a beta of 0.60.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $5.30 billion. During the same quarter last year, the business posted $0.11 EPS. Nutrien’s quarterly revenue was up 18.5% compared to the same quarter last year. Sell-side analysts anticipate that Nutrien Ltd. will post 5.45 earnings per share for the current year.

Nutrien Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.55 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 annualized dividend and a dividend yield of 3.3%. Nutrien’s dividend payout ratio (DPR) is presently 44.81%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on NTR. Jefferies Financial Group upgraded shares of Nutrien from a “hold” rating to a “buy” rating and upped their target price for the stock from $74.00 to $96.00 in a report on Thursday, March 12th. TD Securities restated a “buy” rating on shares of Nutrien in a report on Wednesday, May 6th. Morgan Stanley increased their price objective on shares of Nutrien from $77.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, April 8th. Berenberg Bank set a $65.00 price objective on shares of Nutrien and gave the company a “hold” rating in a research note on Wednesday. Finally, Bank of America upgraded shares of Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective for the company in a research note on Thursday, April 30th. Eleven investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $81.71.

View Our Latest Analysis on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Recommended Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.